Panel Discussion: Oncological Biomarker Testing Paradigm: Determining the right Molecular Test at the Right Time for the Patient: With Biocartis
Time: 3:00 pm
day: Day 1 Track A PM
Details:
- Who makes the decisions at which point—pathology, oncology, diagnostic testing, follow up?
- Patient care: The Pharma perspective
- Where are we failing and where can we do better?
